Subscribe to all Fermentalg financial information by registering here.

 07/10/2024 19:30
Fermentalg once again multi-awarded for the quality of its extra-financial performance
 PDF (283Ko)
 03/10/2024 18:00
Sales of EUR 9.7 million to end September, in line with 2024 full-year target
 PDF (264Ko)
 17/09/2024 18:00
A 1st half-year 2024 marked by the success of the commercial relaunch and the strengthening of strategic alliances
 PDF (403Ko)
 04/07/2024 18:00
Thanks to sales of EUR6.3 million, Fermentalg closes a historic 1st half-year 2024, also marked by its strategic agreement with HuvePharma
 PDF (267Ko)
 18/06/2024 07:30
Successful capital increase for a total amount of EUR12.8m, with the support of Fermentalg's industrial partner HuvePharma and Bpifrance, to create the European champion for microalgae fermentation solutions
 PDF (332Ko)
 17/06/2024 17:35
Launch of a capital increase open to institutional and retail investors for a total of approximately EUR12 million, with the support of HuvePharma, Fermentalg's industrial partner
 PDF (360Ko)
 14/05/2024 13:30
Fermentalg sales ahead of target, successful production transfer
 PDF (336Ko)
 04/04/2024 10:05
After a difficult 2023, Fermentalg confirms in 1st quarter 2024 the return to growth and secures its 2024 sales target
 PDF (250Ko)
 04/04/2024 10:00
Annual results 2023
 PDF (343Ko)
 06/02/2024 20:00
The Shareholders' Meeting approves the proposed transfer of the listing of Fermentalg shares on the Euronext Growth Paris market
 PDF (292Ko)
 26/01/2024 08:30
After EUR4m in sales in 2023, Fermentalg kicks off 2024 with over EUR9m in contracts and orders
 PDF (269Ko)
 22/01/2024 18:00
2024 Financial Agenda
 PDF (247Ko)

All publications will take place after the close of the Euronext markets in Paris.


 

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)